APP and Alzheimer disease: By employing source-reconstructed MEG in cognitively unimpaired individuals carrying mutations in the APP and PSEN1 genes, this study aimed to provide increased insights on quantitative neurophysiological alterations during a true early stage of Alzheimer’s disease.